期刊文献+

普罗帕酮联合电复律转复房颤和房扑的临床观察 被引量:2

Cl Inical Effect of Propafenone and Electrical Cardioversion in Converting Atrial Fibrillation and Atrial Flutter
下载PDF
导出
摘要 目的:探讨普罗帕酮联合电复律转复持续性心房颤动和心房扑动的有效性和安全性。方法:无左室功能不全的房颤和房扑患者55例,电复律前服用负荷量普罗帕酮治疗,未转复者给予电复律,转复后继续口服普罗帕酮维持治疗。结果:50例患者均转为窦性心律,5例患者转复后窦性心律不能维持,早期有效率为90.9%。结论:普罗帕酮联合电复律是持续性房颤和房扑安全有效的治疗方法,值得在临床上推广使用。 Objective:To study the effect of propafenone and electrical cardioversion in convert ing persis- tent at rial fibrillation and atrial flutter. Methods: Fifty- f ire patients with persistent atrial fibrillateion and a- trial flutter without HF underwent a loading dose of propafenone administration before electrical cardio version, then the patients receive propafenone maintenancetherapy. Results: Fifty patients were converted to sinus rhythm, the maintenance rate of sinus rhythm was 90.9 % . Conclusions: propafenone and electrical cardiover- sion may provide an effective and safetive therapy in converting persistent atrial fibrillation and atrial flutter.
出处 《内蒙古医学杂志》 2012年第12期1443-1444,共2页 Inner Mongolia Medical Journal
关键词 房颤和房扑 直流电复律 普罗帕酮 Atrial fibrillation/atrial flutter Electrical cardiover sion Propafenone
  • 相关文献

参考文献4

  • 1陈灏珠.内科学[M] 第4版[M].北京:人民卫生出版社,1996.446. 被引量:32
  • 2陈再嘉 高润霖.冠心病[M].北京:人民卫生出版社,2002.1157. 被引量:9
  • 3胡大一,杨新春,刘彤.心房颤动的复律[J].中华心律失常学杂志,2000,4(1):43-45. 被引量:27
  • 4胡大一,马长生主编..心脏病学实践2002 规范化治疗[M].北京:人民卫生出版社,2002:704.

二级参考文献10

  • 11,Levy S,Breithardt G,Compbell RW,etal.Atrial fibrillation:current knowledge and recommendations for management.Eur HeartJ,1998,19∶1294-1320. 被引量:1
  • 22,Ricard PH,Levy S,Trigano J,et al.Prospective assessment of the minimum energy neededfor external electrical cardioversion of atrial fibrillation.Am J Cardiol,1997,79∶815-816. 被引量:1
  • 33,Pritchett ELC.Management of atrial fibrillation.N Engl J Med,1992,326∶1264-1270. 被引量:1
  • 44,Falk RH,Knowlton AA,Bernard SA,et al.Digoxin for converting recent-onset atrialfibrillation to sinus rhythm.A randomized,double-blind trial.Ann Intern Med,1987,106∶503-506. 被引量:1
  • 55,Falk RH.Proarrhythmia in patients treated for atrial fibrillation or flutter.AnnIntern Med,1992,117∶141-150. 被引量:1
  • 66,Repique LJ,Shah SN,Marais GE.Atrial fibrillation 1992-Management strategies influx.Chest,1992,101∶1095-1103. 被引量:1
  • 77,Coume IP,Thomas O,Leenhardt A.Drug therapy for prevention of atrial fibrillation.Am JCardiol,1996,77(Suppl)∶3A-9A. 被引量:1
  • 88,Middlekauff HR,Wiener I,Stevenson WG.Low-dose amiodarone for atrial fibrillation. Am JCardiol,1993,72∶75F-81F. 被引量:1
  • 99,Karlson BW,Herlitz J,Edvardsson N,et al.Prophylactic treatment after electroconversionof atrial fibrillation.Clin Cardiol,1990,13∶279-286. 被引量:1
  • 1010,Ellenbogen KA,Stambler BS,Wood MA,et al.Efficacy of intravenous ibutilide for rapidtermination of atrial fibrillation and atrial flutter:a dose-response study. J Am CollCardiol,1996,28∶136-139. ( 被引量:1

共引文献65

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部